Trump and the Dems Could Play Nice—or Not
The Beltway view is that Congress and the president will be at an impasse for the next two years. Wall Street, though, sees compromise. Here’s what hangs in the balance.
4 minute read
Global Signals Newsletter
Earnings and Other Headlines
In Bot We Trust
Some Say Retail Bots Are ‘an iPod Moment for AI.’ Are They Really?
The success or failure of bot shoppers is going to come down to trust. So far, the retail establishment has the upper hand.
Good Reads
Investor Circle
Don’t Lose Sleep Over GLP-1s: Why ResMed Is a Bargain
ResMed, whose devices treat sleep apnea, has dropped on unfounded concerns that weight-loss drugs will replace its treatment. The stock is cheap and worth buying at current prices.
Long Read
AppLovin Is Raking in Cash as AI-Driven Revenue Accelerates
Shares of the advertising tech company jump in premarket trading.
1 minute read
Zillow Plunges on Disappointing Loss
Zillow reports a loss of 70 cents a share against expectations for a gain of 16 cents. The home listings platform is counting on its new revenue model to turn things around.
3 minute read
November 2, 2026
Inside China’s Ruthless EV Blitz Upending the World
China is flooding the world with cars, hurting rivals everywhere. Why GM and Lear could thrive anyway.
Long Read
Sorry, Trump. More Russian Oil Won’t Take Down Energy Prices. Here’s What Will.
Trump needs to do more than welcome Russian diesel into the U.S., Michael Bernstam and Steven Rosefielde write.
Long Read
Korea and Taiwan Built Economies on AI. One Failed IPO Shows Their Fragility.
Thetwo economies now risk entering a tech version of the “resource curse,” writes William Pesek.
Long Read
Moderna CEO: Vaccine Isn’t a Disappointment
Moderna’s stock tanked Thursday following a data leak for the drugmaker’s cancer-vaccine candidate, which is co-developed with Merck.
3 minute read
The Mooch on His Broken Record, the Midterms, and Some Advice for Trump
Anthony Scaramucci made headlines for being fired after only 11 days as White House press secretary.
Long Read
How to Pay for Health Expenses, From Gyms to Genetic Testing and More
AgeLab’s Joseph Coughlin suggests creating three “health portfolios” to fund spending for increasingly sophisticated and expensive health and wellness programs.
Long Read
Anthropic’s IPO Is Coming. These Brokerages Are Giving Everyday Investors a Chance to Participate.
The artificial intelligence company intends to allocate a portion of IPO shares to customers of some of the nation’s largest brokerage firms.
2 minute read
Former Stifel Broker Who Allegedly Stole Jewelry Barred From Industry
Brokerage regulator Finra says Ginger Redeker refused to cooperate with its investigation.
1 minute read
Check out Barron's Advisor Rankings
Barron's ranks the best advisors, firms, and teams in the country. The goal is to shine a spotlight on the nation's best financial advisors, with an eye toward raising standards in the industry.
Find an Advisor
Are you ready to search for a financial advisor? We'll match you with advisors who can help.
Recently Viewed Tickers
SymbolPriceChange% Chg
U.S. Stock Movers
Includes common stocks, ADRs and REITs listed on NYSE, Nasdaq or NYSE American with a prior day close of $2 a share or higher and volume of at least 50,000
| Company (Ticker) | Change Percent | Price |
|---|---|---|
| Ohmyhome Ltd. Cl A (OMH) | 432.53% | $15.55 |
| Cricut Inc. Cl A (CRCT) | 48.74% | $8.88 |
| Lyell Immunopharma Inc. (LYEL) | 43.27% | $15.43 |
| Gen Digital Inc. Rt (GENVR) | 42.40% | $4.03 |
| Advantage Solutions Inc. (ADV) | 36.09% | $39.67 |